Noted is that, though treatment of ghrelin enhanced the cytotoxicity of cisplatin to the tumor derived from HO-8910 PM, it did not enhance the side effects of cisplatin to the mice, because ghrelin treatment did not influence the body weight of recipient mice. Here, GHRL is linked to neoplasm.